Keywords: Saudi Arabia, Pharma market, NCB, SPIMACO, Tabuk, Jamjoom, GlaxoSmithKline

Pharma market in Saudi Arabia forecast to rise to 14 billion riyals by 2014

Article | 01 February 2011

Print This

The Saudi Arabian pharmaceutical market is the largest in the Gulf Cooperation Council (GCC). The vast majority of the market ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in